[Central retinal vein occlusion in a patient treated with antiandrogenic drug].
Central retinal vein occlusion (CRVO) is usually seen in older adults and is often associated with systemic vascular disease, this is much less evident in young people. A case report of a 28-year-old woman presented a central retinal vein occlusion in her left eye. This young woman was treated with antiandrogenic drug. Investigations revealed an abnormality of the hemostatic system. The central retinal vein occlusion was resolved and the fundus assumed a normal appearance one-month after the primary episode. Retinal vascular occlusions with antiandrogenic drug may be due to three mechanisms: increased platelet cell aggregation, alteration of fibrinolytic system and vascular endothelium hyperplasia.
Zaoui
M
M
Service d'Ophtalmologie, CHR Notre Dame de Bonsecours, 1, place Philippe de Vigneulles, 57038 Metz Cedex 1.
Cordebar
B
B
Naoun-Hubert
I
I
Sommer
S
S
Rozot
P
P
D000328:Adult; D000726:Androgen Antagonists / Q000009:adverse effects*; D017373:Cyproterone Acetate / Q000009:adverse effects*; D005260:Female; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D012170:Retinal Vein Occlusion / Q000139:chemically induced* / Q000175:diagnosis*; D014792:Visual Acuity
D000726:Androgen Antagonists; D017373:Cyproterone Acetate